Medifocus Inc V.MFS

Primary Symbol: MDFZF

Healthcare Biotechnology

Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The Adaptive Phased Array Microwave Focusing Platform which directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The company through its operations generates revenue from the United States.

EXPM:MDFZF - Post by User

Medifocus Inc

Bullboard Posts

Post by Highrider7on Feb 01, 2014 11:58am

158 Views

Post# 22161912

LEVEL 2 AT THE CLOSE FRIDAY

Looks like she is getting a little less on the bid side and more on the ask and at lower bid / asks.
Possibly the extension of the completed financing is having an effect. It can be pretty hard nowadays for these small bio-companies still developing products to be able to keep raising continued financing. Let's see what happens by February 14th when the financing will be complete.

Level 2 Quote

Shares	Bid Price	Ask Price	Shares
22,000	0.200	0.225	28,500
10,000	0.190	0.230	84,000
32,000	0.185	0.235	16,000
1,000	0.180	0.240	52,000
40,000	0.175	0.245	13,500
26,000	0.160	0.250	2,000
55,000	0.150	0.260	25,000
1,000	0.135	0.270	10,000
12,000	0.110	0.285	53,000
1,500	0.100	0.320	5,000